company background image

Shree Ganesh Remedies BSE:540737 Stock Report

Last Price


Market Cap







05 Oct, 2022


Company Financials
540737 fundamental analysis
Snowflake Score
Future Growth0/6
Past Performance5/6
Financial Health6/6

540737 Stock Overview

Shree Ganesh Remedies Limited engages in the research, development, manufacture, and sale of pharmaceutical drug intermediates and fine chemicals for pharmaceutical industry in India.

Shree Ganesh Remedies Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Shree Ganesh Remedies
Historical stock prices
Current Share Price₹244.65
52 Week High₹429.55
52 Week Low₹220.00
1 Month Change7.35%
3 Month Change-1.65%
1 Year Change-28.66%
3 Year Change381.55%
5 Year Changen/a
Change since IPO892.29%

Recent News & Updates

Shareholder Returns

540737IN PharmaceuticalsIN Market

Return vs Industry: 540737 underperformed the Indian Pharmaceuticals industry which returned -11.3% over the past year.

Return vs Market: 540737 underperformed the Indian Market which returned -1.7% over the past year.

Price Volatility

Is 540737's price volatile compared to industry and market?
540737 volatility
540737 Average Weekly Movement5.1%
Pharmaceuticals Industry Average Movement5.1%
Market Average Movement5.9%
10% most volatile stocks in IN Market9.2%
10% least volatile stocks in IN Market3.8%

Stable Share Price: 540737 is not significantly more volatile than the rest of Indian stocks over the past 3 months, typically moving +/- 5% a week.

Volatility Over Time: 540737's weekly volatility (5%) has been stable over the past year.

About the Company

199597Chandulal Kothia

Shree Ganesh Remedies Limited engages in the research, development, manufacture, and sale of pharmaceutical drug intermediates and fine chemicals for pharmaceutical industry in India. Its pharmaceutical drug intermediates comprise anti-arrhythmic, anti-cancer, anti-depressant, anti-diabetic, anti-diarrheal, anti-fungal, anti-histamine, anti-inflammatory, anti-parasitic, anti-psychotic, anticholinergic, birth-control, cardiovascular, gastrointestinal, neurological disorder, ophthalmic, opioid, and veterinary pharmaceutical ingredient intermediates. The company also offers fine and specialty chemicals, such as agro-chemicals, electronics, flavor and fragrance, life-sciences, and polymer chemicals, as well as other specialty chemicals, including hexamethylendichloride, octamethylendiamine, and suberonitrile for pharmaceutical, agricultural, and chemical applications.

Shree Ganesh Remedies Fundamentals Summary

How do Shree Ganesh Remedies's earnings and revenue compare to its market cap?
540737 fundamental statistics
Market Cap₹2.94b
Earnings (TTM)₹139.28m
Revenue (TTM)₹762.94m


P/E Ratio


P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
540737 income statement (TTM)
Cost of Revenue₹397.88m
Gross Profit₹365.07m
Other Expenses₹225.79m

Last Reported Earnings

Jun 30, 2022

Next Earnings Date


Earnings per share (EPS)11.60
Gross Margin47.85%
Net Profit Margin18.26%
Debt/Equity Ratio0.0%

How did 540737 perform over the long term?

See historical performance and comparison



Current Dividend Yield


Payout Ratio
We’ve recently updated our valuation analysis.


Is 540737 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score


Valuation Score 1/6

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Below Fair Value

  • Significantly Below Fair Value

  • Analyst Forecast

Key Valuation Metric

Which metric is best to use when looking at relative valuation for 540737?

Other financial metrics that can be useful for relative valuation.

540737 key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue3.8x
Enterprise Value/EBITDA15x
PEG Ration/a

Price to Earnings Ratio vs Peers

How does 540737's PE Ratio compare to its peers?

540737 PE Ratio vs Peers
The above table shows the PE ratio for 540737 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyPEEstimated GrowthMarket Cap
Peer Average17.3x
540937 Medico Remedies
526953 Venus Remedies
500009 Ambalal Sarabhai Enterprises
524212 Wanbury
540737 Shree Ganesh Remedies

Price-To-Earnings vs Peers: 540737 is expensive based on its Price-To-Earnings Ratio (21.1x) compared to the peer average (17.3x).

Price to Earnings Ratio vs Industry

How does 540737's PE Ratio compare vs other companies in the IN Pharmaceuticals Industry?

Price-To-Earnings vs Industry: 540737 is good value based on its Price-To-Earnings Ratio (21.1x) compared to the Indian Pharmaceuticals industry average (24.1x)

Price to Earnings Ratio vs Fair Ratio

What is 540737's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

540737 PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio21.1x
Fair PE Ration/a

Price-To-Earnings vs Fair Ratio: Insufficient data to calculate 540737's Price-To-Earnings Fair Ratio for valuation analysis.

Share Price vs Fair Value

What is the Fair Price of 540737 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 540737 (₹244.65) is trading above our estimate of fair value (₹142.1)

Significantly Below Fair Value: 540737 is trading above our estimate of fair value.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.

Discover undervalued companies

Future Growth

How is Shree Ganesh Remedies forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

Future Growth Score


Future Growth Score 0/6

  • Earnings vs Savings Rate

  • Earnings vs Market

  • High Growth Earnings

  • Revenue vs Market

  • High Growth Revenue

  • Future ROE


Forecasted Pharmaceuticals & Biotech industry annual growth in earnings

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Shree Ganesh Remedies has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

Discover growth companies

Past Performance

How has Shree Ganesh Remedies performed over the past 5 years?

Past Performance Score


Past Performance Score 5/6

  • Quality Earnings

  • Growing Profit Margin

  • Earnings Trend

  • Accelerating Growth

  • Earnings vs Industry

  • High ROE


Historical annual earnings growth

Earnings and Revenue History

Quality Earnings: 540737 has high quality earnings.

Growing Profit Margin: 540737's current net profit margins (18.3%) are lower than last year (19.7%).

Past Earnings Growth Analysis

Earnings Trend: 540737's earnings have grown significantly by 23% per year over the past 5 years.

Accelerating Growth: 540737's earnings growth over the past year (37.7%) exceeds its 5-year average (23% per year).

Earnings vs Industry: 540737 earnings growth over the past year (37.7%) exceeded the Pharmaceuticals industry -2.1%.

Return on Equity

High ROE: 540737's Return on Equity (22.6%) is considered high.

Discover strong past performing companies

Financial Health

How is Shree Ganesh Remedies's financial position?

Financial Health Score


Financial Health Score 6/6

  • Short Term Liabilities

  • Long Term Liabilities

  • Debt Level

  • Reducing Debt

  • Debt Coverage

  • Interest Coverage

Financial Position Analysis

Short Term Liabilities: 540737's short term assets (₹449.1M) exceed its short term liabilities (₹150.4M).

Long Term Liabilities: 540737's short term assets (₹449.1M) exceed its long term liabilities (₹4.0M).

Debt to Equity History and Analysis

Debt Level: 540737 is debt free.

Reducing Debt: 540737 has no debt compared to 5 years ago when its debt to equity ratio was 3%.

Debt Coverage: 540737 has no debt, therefore it does not need to be covered by operating cash flow.

Interest Coverage: 540737 has no debt, therefore coverage of interest payments is not a concern.

Balance Sheet

Discover healthy companies


What is Shree Ganesh Remedies's current dividend yield, its reliability and sustainability?

Dividend Score


Dividend Score 1/6

  • Notable Dividend

  • High Dividend

  • Stable Dividend

  • Growing Dividend

  • Earnings Coverage

  • Cash Flow Coverage


Current Dividend Yield

Dividend Yield vs Market

Shree Ganesh Remedies Dividend Yield vs Market
How does Shree Ganesh Remedies dividend yield compare to the market?
SegmentDividend Yield
Company (Shree Ganesh Remedies)0.2%
Market Bottom 25% (IN)0.4%
Market Top 25% (IN)1.6%
Industry Average (Pharmaceuticals)0.9%
Analyst forecast in 3 Years (Shree Ganesh Remedies)n/a

Notable Dividend: 540737's dividend (0.2%) isn’t notable compared to the bottom 25% of dividend payers in the Indian market (0.36%).

High Dividend: 540737's dividend (0.2%) is low compared to the top 25% of dividend payers in the Indian market (1.59%).

Stability and Growth of Payments

Stable Dividend: 540737 has been paying a dividend for less than 10 years and during this time payments have been volatile.

Growing Dividend: 540737 has only been paying a dividend for 4 years, and since then payments have fallen.

Earnings Payout to Shareholders

Earnings Coverage: With its low payout ratio (4.3%), 540737's dividend payments are thoroughly covered by earnings.

Cash Payout to Shareholders

Cash Flow Coverage: 540737 is paying a dividend but the company has no free cash flows.

Discover strong dividend paying companies


How experienced are the management team and are they aligned to shareholders interests?


Average board tenure


Chandulal Kothia (59 yo)





Mr. Chandulal Manubhai Kothia is Promoter, Chairman and Managing Director of Shree Ganesh Remedies Limited. Mr. Kothia has experience of more than two decades in the field of Manufacturing of pharmaceutica...

CEO Compensation Analysis

Chandulal Kothia's Compensation vs Shree Ganesh Remedies Earnings
How has Chandulal Kothia's remuneration changed compared to Shree Ganesh Remedies's earnings?
DateTotal Comp.SalaryCompany Earnings
Jun 30 2022n/an/a


Mar 31 2022₹10m₹10m


Dec 31 2021n/an/a


Sep 30 2021n/an/a


Jun 30 2021n/an/a


Mar 31 2021₹6m₹6m


Dec 31 2020n/an/a


Sep 30 2020n/an/a


Jun 30 2020n/an/a


Mar 31 2020₹5m₹5m


Dec 31 2019n/an/a


Sep 30 2019n/an/a


Jun 30 2019n/an/a


Mar 31 2019₹3m₹3m


Dec 31 2018n/an/a


Sep 30 2018n/an/a


Jun 30 2018n/an/a


Mar 31 2018₹5m₹5m


Compensation vs Market: Chandulal's total compensation ($USD121.66K) is above average for companies of similar size in the Indian market ($USD44.15K).

Compensation vs Earnings: Chandulal's compensation has increased by more than 20% in the past year.

Board Members

Experienced Board: 540737's board of directors are considered experienced (3.8 years average tenure).


Who are the major shareholders and have insiders been buying or selling?

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of 540737?
Owner TypeNumber of SharesOwnership Percentage
Private Companies102,3910.9%
General Public2,604,52621.7%
Individual Insiders9,299,81077.5%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 9 shareholders own 78.31% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
Chandulal Kothia
7,321,876₹1.8b0%no data
Ashokkumar Kothia
996,030₹243.7m0%no data
Babu Kotadiya
213,409₹52.2m0%no data
Gunjan Dhorajiya
202,773₹49.6m0%no data
Trupti Patel
173,495₹42.4m0%no data
Madras Mahadev
145,309₹35.5m0%no data
Kailashben Bhandari
126,918₹31.1m0%no data
Gunjan Kothia
120,000₹29.4m0%no data
Susma Textiles LLP
102,391₹25.0m0%no data

Company Information

Shree Ganesh Remedies Limited's employee growth, exchange listings and data sources

Key Information

  • Name: Shree Ganesh Remedies Limited
  • Ticker: 540737
  • Exchange: BSE
  • Founded: 1995
  • Industry: Pharmaceuticals
  • Sector: Pharmaceuticals & Biotech
  • Implied Market Cap: ₹2.937b
  • Shares outstanding: 12.01m
  • Website:

Number of Employees


  • Shree Ganesh Remedies Limited
  • Plot No. 6011
  • G.I.D.C Estate
  • Ankleshwar
  • Gujarat
  • 393002
  • India


TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
540737BSE (Mumbai Stock Exchange)YesEquity SharesININROct 2017

Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2022/10/05 00:00
End of Day Share Price2022/10/04 00:00
Annual Earnings2022/03/31

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.